Self-expanding valves (SEVs) are associated with less prosthesis-patient mismatch (PPM) in East Asian patients with small aortic annuli (SAA) undergoing TAVR, compared with balloon-expandable valves ...

Further work is necessary in the cardiology field to create a safe and inclusive space for cardiovascular lesbian, gay, bisexual, transgender and queer (LGBTQ+) trainees and physicians, as well as ...

Mechanical surgical aortic valve replacement (AVR) was associated with lower all-cause mortality in patients ≤60 years old compared with bioprosthetic AVR, according to a study on the longitudinal ...

An expert panel report, the last of three in a special series published in JACC: CardioOncology, focuses on evaluating the current evidence and highlighting gaps in both evidence and guideline ...

"Wildfires, compound extreme events, climate change and cardiovascular health," are the central theme of an editorial authored by Kai Chen, PhD; Yuan Lu, ScD, and Harlan M. Krumholz, MD, SM, FACC; in ...

Assessment of vessel lesions using optical ultrasonic flow ratio (OUFR) based on hybrid intravascular ultrasound-optical coherence tomography (IVUS-OCT) is safe and effective and provided better ...

Cardiology fellowships provide robust didactic education via structured and standardized curriculum based on the Accreditation Council for Graduate Medical Education requirements. However, the same is ...

Women who experienced any of five major adverse pregnancy outcomes have increased risk of heart failure (HF) up to 46 years later and need early preventive actions and long-term clinical care to ...

The U.S. Food and Drug Administration (FDA) announced on Jan. 13 that Philips is correcting the Monitoring Service Application used with Mobile Cardiac Telemetry Monitoring as some electrocardiogram ...

A novel artificial intelligence (AI) model applied to a 12-lead electrocardiogram (ECG) image was able to identify individuals at elevated risk of heart failure (HF) across multinational cohorts ...

The SUMMIT trial compared the safety and efficacy of tirzepatide among patients with heart failure with preserved ejection fraction (HFpEF) and obesity. Results from the trial concluded that treatment ...